SCHEMBL1997397

SCHEMBL1997397

COc1ccc2c(c1)c(C(=O)c1nc(-c3cnccn3)no1)c(Cl)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.38
PLA2G2A P14555 3/20 0.37
TP53 P04637 2/20 0.37
ALDH1A1 P00352 4/20 0.36
PKM P14618 2/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 6/20 0.35
KMT2A Q03164 2/20 0.35
LIMK1 P53667 2/20 0.35
LIMK2 P53671 2/20 0.35
LMNA P02545 3/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 1/20 0.34
RGS12 O14924 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2003563 0.93 PLA2G2A (0.42) PTGS2PLA2G2ATP53ALDH1A1PKM
SCHEMBL2004146 0.91 ALDH1A1 (0.39) TP53ALDH1A1PKMPTGDR2NPC1
SCHEMBL2002568 0.91 PKM (0.43) PTGS2PLA2G2AALDH1A1PKMNPC1
SCHEMBL2001691 0.90 NPC1 (0.41) PLA2G2ATP53ALDH1A1PKMPTGDR2
SCHEMBL2003124 0.89 PLA2G2A (0.37) PLA2G2ATP53ALDH1A1PKMPTGDR2
SCHEMBL2006584 0.88 ALDH1A1 (0.40) TP53ALDH1A1PKMNPC1RAB9A
SCHEMBL2000940 0.88 PLA2G2A (0.40) PLA2G2ATP53ALDH1A1PKMPTGDR2
SCHEMBL2001925 0.88 LMNA (0.41) PTGS2PLA2G2ATP53PKMNPC1
SCHEMBL2007846 0.88 NPC1 (0.40) PLA2G2ATP53NPC1RAB9AMAPT
SCHEMBL2004681 0.87 PIEZO1 (0.39) PTGS2PLA2G2ATP53ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PTGS2 45/4885PLA2G2A 3285/4885TP53 2579/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT PTGS2 460/4885PLA2G2A 326/4885TP53 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.